Intragastric Balloons Market
Report ID: SQMIG35A4192
Report ID: SQMIG35A4192
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A4192 |
Region:
Global |
Published Date: July, 2026
Pages:
157
|Tables:
169
|Figures:
79
Global Intragastric Balloons Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 203.34 Million in 2025 to USD 485.4 Million by 2033, growing at a CAGR of 11.4% during the forecast period (2026-2033).
Expanding insurance reimbursement for obesity therapies is the key to unlocking revenue and patient adoption. As payers recognize the benefit of reduced diabetes and cardiovascular risk, they start to cover balloon placement, which motivates GI centers to invest in training and equipment. The data support this effect: After Medicare added limited Orbera coverage in 2022, U.S. clinics saw a 35% increase in procedures, while European hospitals partnered with platforms to track diet compliance, improving outcomes and justifying reimbursements. That momentum creates an opportunity for manufacturers to roll out biodegradable balloons that reduce endoscopies, putting them in a position to grab market share as Asian regulators fast-track innovations.
How is AI Enhancing Patient Selection and Outcomes in the Intragastric Balloon Market?
Artificial intelligence is transforming the intragastric balloon market, shifting the selection of candidates to a data-driven process. Machine-learning models merge electronic health records, metabolic profiles and lifestyle questionnaires to predict which patients will experience meaningful weight loss and avoid complications. This predictive insight helps clinicians match balloon type and volume to individual anatomy, schedule follow-up visits, and intervene early if adverse trends develop. Clinics report smoother onboarding, increased compliance to dietary protocols and less repeat procedures in the real world. This, in turn, enables providers to expand their service lines and insurers to realize lower overall costs, adding to the market’s momentum.
In April 2024, Apollo Endosurgery unveiled an AI-powered decision-support system that analyzes patient histories, forecasts optimal balloon placement, and integrates live weight trajectories and alerts about adverse events. Clinicians can personalize therapy before complications arise, speeding up case triage, enhancing outcomes and bolstering confidence in balloon therapy as a first-line non-surgical option.
Market snapshot - (2026-2033)
Global Market Size
USD 182.5 Million
Largest Segment
Single Balloons
Fastest Growth
Swallowable Balloons
Growth Rate
11.42% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global intragastric balloons market is segmented by product type, material, procedure, application, end-user and region. Based on product type, the market is segmented into single balloons, dual balloons and swallowable balloons. Based on material, the market is segmented into silicone, saline-filled and gas-filled. Based on procedure, the market is segmented into endoscopic placement and swallowable (non-endoscopic). Based on application, the market is segmented into obesity treatment and pre-bariatric surgery. Based on end-user, the market is segmented into hospitals, bariatric centers and outpatient clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Single balloons segment is dominating the market because clinicians prefer its simplicity and proven efficacy, which makes the placement process easier and reduces the procedure time. The intrinsic design leads to a lower number of components, thus reducing the risk of mechanical failure and increasing patient comfort during the period of therapy. This reliability builds confidence for physicians and patients and helps to reinforce its preferred status in clinical protocols and drive sustained demand across treatment programs throughout the care continuum globally.
However, the fastest growing segment is the dual balloons segment, as its dual chamber design allows for higher volume capacity, which in turn, provides better satiety and weight loss outcomes. Technology is driving new clinical protocols and market growth, with continuous innovation and patient demand for better efficacy driving adoption.
Silicone segment is dominating the market owing to biocompatibility and durability making it the choice of materials for long term gastric applications. Its inert nature reduces adverse reactions and its flexibility guarantees comfort to the patient and consistent performance during the therapy cycle. These properties create physician confidence and patient acceptance and thus silicone is the basis of most commercially available balloon solutions. They also allow manufacturers to create product lines that differ to address different clinical needs.
Meanwhile, the gas-filled segment is witnessing the highest growth momentum owing to its lightweight nature, which facilitates faster balloon deflation and easy removal, thereby enhancing patient experience. Its adoption and scope for therapeutic applications are being driven by the adoption of emerging minimally invasive procedures and continued research into gas compositions, opening new avenues for new entrants to the market to differentiate.
To get detailed segments analysis, Request a Free Sample Report
The region has a mature healthcare ecosystem with a wide coverage of insurers and a proactive clinical community eager to adopt minimally invasive weight-management solutions. Strong reimbursement structures lower patient cost barriers, and leading academic institutions and research hospitals fuel ongoing innovation and clinical validation. The devices will be available quickly because of established manufacturers and strong supply chain. Increased awareness of obesity-related health risks among the general population is also driving demand, and regulatory pathways provide clarity and speed for product introductions, helping to strengthen North America’s leading position.
Intragastric balloons market outlook in the United States is propelled by a broad network of specialized bariatric clinics and gastroenterology practices that champion early‑stage interventions. Payers increasingly recognize the value of balloon therapy as a cost‑effective complement to lifestyle programs, facilitating higher adoption rates. Ongoing collaboration between manufacturers and clinical investigators sustains a pipeline of refined devices, while patient education initiatives expand acceptance across diverse demographic groups.
Intragastric balloons market forecast in Canada gains strength from a publicly funded health system that emphasizes preventive care and integrated treatment pathways. Provincial health authorities support pilot programs that showcase clinical outcomes, encouraging broader clinician endorsement. Canadian medical centers prioritize evidence‑based practice, fostering confidence among practitioners and patients alike. Collaborative research networks further enhance knowledge sharing, positioning the market for steady expansion.
Europe’s growth is driven by a combination of positive health policies, growing recognition of obesity as a public health problem and aligned regulatory standards that enable access across member states. Reimbursement pathways are evolving such that balloon therapy is included in comprehensive weight-management packages with less out-of-pocket costs. A cluster of specialized research institutions and clinics that support clinical trials and post-market studies, thereby increasing confidence of health care professionals. The market momentum is picking up pace as the demand for less invasive weight-loss options among consumers is rising and strategic collaborations between manufacturers and medical societies in Europe are taking root.
Intragastric balloons market regional outlook in Germany is anchored by a well‑established network of university hospitals and private bariatric centers that lead adoption of innovative therapies. Strong insurance frameworks increasingly incorporate balloon procedures, facilitating patient access. Collaborative research initiatives between industry and academic entities generate robust clinical data, reinforcing practitioner confidence. The market benefits from a culture of early technology adoption, driving sustained growth.
Intragastric balloons market regional forecast in the United Kingdom expands rapidly due to proactive public health campaigns and NHS pathways that integrate balloon therapy into multidisciplinary obesity programmes. Specialist clinics across major cities provide streamlined referral processes, enhancing patient reach. Ongoing clinical research and guideline updates promote practitioner awareness, while private providers complement public offerings, broadening the treatment landscape.
Intragastric balloons market analysis in France is emerging as clinicians increasingly recognize balloon therapy as a viable bridge to lifestyle modification. Hospital networks and private practices are gradually incorporating the technique into obesity management protocols. Reimbursement discussions are advancing, and patient interest is rising alongside broader acceptance of minimally invasive options. Collaborative studies between French research centres and device makers support market credibility.
The Asia Pacific is gaining traction, driven by increasing health awareness, expanding urban middle classes and a surge in weight-related diseases, which are fueling demand for affordable solutions. Regulatory agencies are opening up clear pathways to market entry to ensure safety and are encouraging manufacturers to target the region. Specialized clinics and private hospitals are ramping up minimally invasive offerings, while medical tourism amplifies procedural volumes. Local distributors partner with global innovators to accelerate technology transfer and create a vibrant market growth environment in the region.
Intragastric balloons market penetration in Japan benefits from a sophisticated endoscopy community that embraces advanced, low‑risk weight‑management solutions. Health insurers are increasingly acknowledging balloon therapy as part of comprehensive obesity care, improving patient affordability. Leading medical centers conduct rigorous outcome studies, fostering clinician confidence. Cultural shifts toward preventive health amplify interest in minimally invasive options, supporting market development.
Intragastric balloons industry in South Korea is propelled by a dynamic private healthcare sector that rapidly integrates cutting‑edge technologies. Insurance providers are expanding coverage criteria for balloon procedures, reducing financial obstacles for patients. Academic hospitals conduct collaborative research that informs practice guidelines, while public awareness campaigns highlight the benefits of non‑surgical weight loss. This confluence of factors strengthens the market’s trajectory.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Growing Preference For Non Surgical Options
Advancements In Balloon Technology
Stringent Regulatory Approval Processes
Limited Reimbursement Coverage
Request Free Customization of this report to help us to meet your business objectives.
The global intragastric balloon market is characterized by competition among a relatively small number of specialized medical device manufacturers that compete through product innovation, clinical evidence generation, geographic expansion, physician training programs, and regulatory approvals. Companies including Allurion, Spatz Medical, Apollo Endosurgery, ReShape Lifesciences, and other bariatric device manufacturers continue to develop minimally invasive weight management technologies that improve patient comfort, treatment effectiveness, and procedural efficiency. Growing demand for non-surgical obesity treatments, increasing obesity prevalence, and expanding reimbursement discussions are encouraging manufacturers to strengthen commercial partnerships with healthcare providers and broaden access to endoscopic weight-loss therapies, intensifying competition across global markets.
Top Player’s Company Profile
Recent Developments in the Intragastric Balloons Market
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. As per SkyQuest analysis, the global intragastric balloons market is being propelled primarily by a growing preference for non‑surgical weight‑loss options, which expands the eligible patient pool and encourages clinicians to adopt endoscopic procedures. A second driver comes from continual advancements in balloon technology, such as adjustable volumes and biodegradable shells, that improve comfort and reduce complications, further boosting adoption. The market is constrained by stringent regulatory approval processes that lengthen time‑to‑market and increase costs, limiting participation from smaller innovators. North America remains the dominating region thanks to mature reimbursement frameworks and strong clinical demand, while the single‑balloon segment leads in volume because of its simplicity, proven efficacy, and lower procedural risk.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 182.5 Million |
| Market size value in 2033 | USD 485.4 Million |
| Growth Rate | 11.42% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Intragastric Balloons Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Intragastric Balloons Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Intragastric Balloons Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Intragastric Balloons Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Intragastric Balloons Market size was valued at USD 182.5 Million in 2024 and is poised to grow from USD 203.34 Million in 2025 to USD 485.4 Million by 2033, growing at a CAGR of 11.42% during the forecast period (2026-2033).
The intragastric balloon market is shaped by intense rivalry as manufacturers vie for differentiation through technology upgrades and strategic alliances. Recent M&A activity, such as Apollo Endosurgery’s acquisition of the balloon portfolio from ReShape, and partnerships like Allurion’s collaboration with a major insurer to bundle its swallow‑able Elipse system, illustrate how firms leverage consolidation and joint go‑to‑market programs to accelerate adoption and outpace rivals. 'Apollo Endosurgery (ORBERA)', 'Obalon Therapeutics (ReShape Lifesciences)', 'Reshape Medical (ReShape Lifesciences)', 'Spatz Medical', 'Allurion Technologies (Elipse)', 'Endalis (Endotools)', 'BMI Medical (Helioscopie)', 'Medical Innovation Developpement (MID)', 'Bioenterics Corporation (Allergan/AbbVie)', 'Medsil (Russian)', 'Medicone Medical', 'Ethicon (J&J)', 'IPSA (Surgical Innovation)', 'Bariatric Balloon Technologies', 'Cousin Biotech', 'Meritex', 'Medigus Ltd.', 'Silimed', 'Endo-Surf Inc.', 'AJM Medical'
The rising consumer interest in non surgical weight management solutions drives demand for intragastric balloons, as patients seek effective alternatives that avoid operative risks and lengthy recovery periods, fostering greater adoption of endoscopic procedures and expanding the eligible patient pool across diverse demographic groups, thereby stimulating manufacturer investment in product development and market penetration strategies. The positive perception of safety, combined with increased physician confidence and the availability of minimally invasive techniques, further encourages clinical referrals and supports long term growth of the intragastric balloon sector.
Minimally Invasive Preference Surge: Patients and clinicians increasingly favor procedures that reduce hospital stay, postoperative pain, and recovery time, positioning intragastric balloon therapy as a preferred alternative to surgical bariatric options. Providers are expanding outpatient capabilities, leveraging endoscopic platforms that streamline insertion and removal, while insurers recognize cost‑efficiency advantages. This shift drives manufacturers to refine balloon materials for durability and ease of deployment, fostering collaborations with endoscopy device firms to create integrated solutions that align with the broader minimally invasive healthcare agenda globally today.
Why does North America Dominate the Global Intragastric Balloons Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
